Correction: Advances in immunotherapy for triple-negative breast cancer.

Liu, Yang; Hu, Yueting; Xue, Jinqi; Li, Jingying; Yi, Jiang; Bu, Jiawen; Zhang, Zhenyong; Qiu, Peng; Gu, Xi

Liu, Yang; Hu, Yueting; Xue, Jinqi; Li, Jingying; Yi, Jiang; Bu, Jiawen; Zhang, Zhenyong; Qiu, Peng; Gu, Xi.

Affiliation

Liu Y; Department of Oncology, Shengjing Hospital of China Medical University, Shenyang, 110004, Liaoning Province, China.
Hu Y; Department of Oncology, Shengjing Hospital of China Medical University, Shenyang, 110004, Liaoning Province, China.
Xue J; Department of Oncology, Shengjing Hospital of China Medical University, Shenyang, 110004, Liaoning Province, China.
Li J; Department of Health Management, Shengjing Hospital of China Medical University, Shenyang, 110004, Liaoning Province, China.
Yi J; Department of Oncology, Shengjing Hospital of China Medical University, Shenyang, 110004, Liaoning Province, China.
Bu J; Department of Oncology, Shengjing Hospital of China Medical University, Shenyang, 110004, Liaoning Province, China.
Zhang Z; Department of Oncology, Shengjing Hospital of China Medical University, Shenyang, 110004, Liaoning Province, China. jadegx@163.com.
Qiu P; Department of Anesthesiology, Shengjing Hospital of China Medical University, Shenyang, 110004, Liaoning Province, China. storm0513@163.com.
Gu X; Department of Oncology, Shengjing Hospital of China Medical University, Shenyang, 110004, Liaoning Province, China. zzyzz-doc@163.com.

Mol Cancer ; 22(1): 154, 2023 Sep 14.

Article in En | MEDLINE | ID: mdl-37710293

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Mol Cancer Journal subject: NEOPLASIAS Year: 2023 Document type: Article Affiliation country: China Country of publication: Reino Unido

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google